Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on General Meeting and Admission Date

14 Jul 2021 07:00

RNS Number : 1468F
Bidstack Group PLC
14 July 2021
 

14 July 2021

Bidstack Group Plc

("Bidstack" or the "Company")

Update on General Meeting and Admission Date

Bidstack Group Plc (AIM: BIDS.L), notes that, on 12 July 2021, the UK government announced it had decided to move to Step 4 of the roadmap it published in February 2021, its step-by-step plan to ease COVID-19 restrictions in England cautiously. Step 4 is a new phase of continued caution whilst managing the risks of COVID-19.

While many of the legal restrictions the Government has imposed throughout the pandemic will be lifted, cautious guidance will remain in place, making it clear this is not yet a return to normal. Certain key protections remain in place including minimising the number, proximity and duration of social contacts and encouraging and supporting use of the NHS COVID Pass to help limit the risk of infection.

With reference to its upcoming General Meeting, convened for 11.00 am on 19 July 2021, shareholders remain strongly advised to complete, sign and return their Forms of Proxy to the Company's Registrars, Neville Registrars Limited, Neville House, Steelpark Road, Halesowen B62 8HD as soon as possible and, in any event, so as to be received by 11.00 a.m. on 15 July 2021. Shareholders holding ordinary shares in CREST, may appoint a proxy by completing and transmitting a CREST proxy instruction so that it is received by not later than 11:00 a.m. on 15 July 2021.

Shareholders will not be precluded from attending the General Meeting in person. However attendance at the General Meeting will be strictly limited to those shareholders whose names appear in the register of members at the close of business on 16 July 2021 and who have an NHS COVID pass. The Board reserves the right to exclude shareholders in the event that it perceives that there is any risk to the Company's employees or any other persons at the Company's premises. Any person displaying symptoms of COVID-19 will be refused entry.

It remains the intention of the Board to conduct the vote on each of the resolutions to be put to the General Meeting on a poll.

In addition, in the event the resolutions to be put to the General Meeting are passed, the Admission Date for the New Ordinary Shares is now expected to be on 23 July 2021.

-ENDS-

Contacts

Bidstack Group Plc

James Draper, CEO

 

via Buchanan

SPARK Advisory Partners Limited (Nomad)

Mark Brady / Neil Baldwin / James Keeshan

+44 (0) 203 368 3550

Cenkos Securities Plc (Joint Broker)

Michael Johnson / Dale Bellis (Sales)

 

Giles Balleny (Corporate Finance) 

 

+44 (0) 20 7397 1933 

+44 (0) 20 7397 1928

+44 (0) 20 7397 8951

Stifel Nicholas Europe Limited (Joint Broker)

Fred Walsh / Luisa Orsini Baroni

 

 

+44 (0) 20 7710 7600

 

Buchanan Communications Limited

Chris Lane / Stephanie Watson / Kim van Beeck

bidstack@buchanan.uk.com

 

+44 (0) 20 7466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKNBDNBKBQOD
Date   Source Headline
17th Aug 200711:30 amRNSAIM Rule 26
19th Jul 20079:00 amRNSBUPA completes investment
11th Jul 20079:22 amRNSApplication for Listing
3rd Jul 200710:45 amRNSApplication for Listing
22nd Jun 20077:01 amRNSBUPA take 29.9% stake
11th Jun 20077:00 amRNSAgreement with Alliance Boots
5th Jun 20077:01 amRNSAgreement with Esporta
29th May 20071:03 pmRNSResult of EGM
4th May 20072:53 pmRNSNotice of EGM
25th Apr 20077:00 amRNSInterim Results
13th Apr 200712:31 pmRNSDirector/PDMR Shareholding
23rd Jan 20078:42 amRNSTotal Voting Rights
19th Jan 20072:37 pmRNSPlacing
15th Dec 20062:45 pmRNSTotal Voting Rights
14th Dec 20066:02 pmRNSResult of AGM
14th Nov 20067:02 amRNSFinal Results
26th Jul 20068:08 amRNSAcquisition
5th Jun 20067:00 amRNSAgreement with PruHealth
5th May 20069:30 amRNSContract Win
12th Apr 20064:37 pmRNSOptions Granted
10th Apr 200610:34 amRNSInterim Results
27th Feb 20067:00 amRNSDisposal of Liberation
9th Feb 20067:00 amRNSContract with Leisure Op.
16th Dec 20052:27 pmRNSAGM Statement
23rd Nov 20057:01 amRNSUS Licensing Agreement
16th Nov 20057:02 amRNSFinal Results
25th Aug 20054:42 pmRNSDirector/PDMR Shareholding
4th Aug 200512:22 pmRNSShare Price/Press Speculation
25th Jul 20057:00 amRNSDirectors Holding / Update
5th May 20054:56 pmRNSResult of EGM
18th Apr 20057:00 amRNSInterim Results
13th Apr 20057:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.